aluates Reports

$ 0.0

Automative

Global CGT CDMO Market Research Report 2026

Published Date: 2026-04-24

Report Code: QYRE-Auto-34J6684

Global CGT CDMO Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global CGT CDMO Market Research Report 2026

Code: QYRE-Auto-34J6684

Report

2026-04-24

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

WuXi AppTec

OBiO

GenScript

Porton

Lonza

Pharmaron

Catalent

Thermo Fisher

Oxford Biomedica (OXB)

Novartis

ACG Biologics

Charles River

CGT CDMO Market Size

The global CGT CDMO market was valued at US$ 6891 million in 2025 and is anticipated to reach US$ 30550 million by 2032, at a CAGR of 24.1% from 2026 to 2032.

CGT CDMO Market

CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.

Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

This report delivers a comprehensive overview of the global CGT CDMO market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding CGT CDMO. The CGT CDMO market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global CGT CDMO market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist CGT CDMO manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of CGT CDMO Market Report

Report Metric	Details
Report Name	CGT CDMO Market
Accounted market size in 2025	US$ 6891 million
Forecasted market size in 2032	US$ 30550 million
CAGR	24.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Immune Cells Stem Cells Viral Vectors Plasmid DNA
Segment by Application	Pharmaceutical and Biotechnology Companies Research and Academic Institutions Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis, OBiO, GenScript, Pharmaron, Porton
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for CGT CDMO companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is CGT CDMO Market growing?

Ans: The CGT CDMO Market witnessing a CAGR of 24.1% during the forecast period 2026-2032.

What is the CGT CDMO Market size in 2032?

Ans: The CGT CDMO Market size in 2032 will be US$ 30550 million.

What is the market share of major companies in CGT CDMO Market?

Ans: The top three players hold a share over 60%.

What is the CGT CDMO Market share by region?

Ans: North America is the largest market, has a share about 50%.

What is the CGT CDMO Market share by type?

Ans: In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

Who are the main players in the CGT CDMO Market report?

Ans: The main players in the CGT CDMO Market are Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis, OBiO, GenScript, Pharmaron, Porton

What are the Application segmentation covered in the CGT CDMO Market report?

Ans: The Applications covered in the CGT CDMO Market report are Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Hospital, Others

What are the Type segmentation covered in the CGT CDMO Market report?

Ans: The Types covered in the CGT CDMO Market report are Immune Cells, Stem Cells, Viral Vectors, Plasmid DNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CGT CDMO Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Immune Cells

1.2.3 Stem Cells

1.2.4 Viral Vectors

1.2.5 Plasmid DNA

1.3 Market by Application

1.3.1 Global CGT CDMO Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research and Academic Institutions

1.3.4 Hospital

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CGT CDMO Market Perspective (2021–2032)

2.2 Global CGT CDMO Growth Trends by Region

2.2.1 Global CGT CDMO Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 CGT CDMO Historic Market Size by Region (2021–2026)

2.2.3 CGT CDMO Forecasted Market Size by Region (2027–2032)

2.3 CGT CDMO Market Dynamics

2.3.1 CGT CDMO Industry Trends

2.3.2 CGT CDMO Market Drivers

2.3.3 CGT CDMO Market Challenges

2.3.4 CGT CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CGT CDMO Players by Revenue

3.1.1 Global Top CGT CDMO Players by Revenue (2021–2026)

3.1.2 Global CGT CDMO Revenue Market Share by Players (2021–2026)

3.2 Global Top CGT CDMO Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by CGT CDMO Revenue

3.4 Global CGT CDMO Market Concentration Ratio

3.4.1 Global CGT CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CGT CDMO Revenue in 2025

3.5 Global Key Players of CGT CDMO Head Offices and Areas Served

3.6 Global Key Players of CGT CDMO, Products and Applications

3.7 Global Key Players of CGT CDMO, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 CGT CDMO Breakdown Data by Type

4.1 Global CGT CDMO Historic Market Size by Type (2021–2026)

4.2 Global CGT CDMO Forecasted Market Size by Type (2027–2032)

5 CGT CDMO Breakdown Data by Application

5.1 Global CGT CDMO Historic Market Size by Application (2021–2026)

5.2 Global CGT CDMO Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America CGT CDMO Market Size (2021–2032)

6.2 North America CGT CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America CGT CDMO Market Size by Country (2021–2026)

6.4 North America CGT CDMO Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CGT CDMO Market Size (2021–2032)

7.2 Europe CGT CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe CGT CDMO Market Size by Country (2021–2026)

7.4 Europe CGT CDMO Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific CGT CDMO Market Size (2021–2032)

8.2 Asia-Pacific CGT CDMO Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific CGT CDMO Market Size by Region (2021–2026)

8.4 Asia-Pacific CGT CDMO Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America CGT CDMO Market Size (2021–2032)

9.2 Latin America CGT CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America CGT CDMO Market Size by Country (2021–2026)

9.4 Latin America CGT CDMO Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CGT CDMO Market Size (2021–2032)

10.2 Middle East & Africa CGT CDMO Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa CGT CDMO Market Size by Country (2021–2026)

10.4 Middle East & Africa CGT CDMO Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Catalent

11.1.1 Catalent Company Details

11.1.2 Catalent Business Overview

11.1.3 Catalent CGT CDMO Introduction

11.1.4 Catalent Revenue in CGT CDMO Business (2021–2026)

11.1.5 Catalent Recent Development

11.2 Lonza

11.2.1 Lonza Company Details

11.2.2 Lonza Business Overview

11.2.3 Lonza CGT CDMO Introduction

11.2.4 Lonza Revenue in CGT CDMO Business (2021–2026)

11.2.5 Lonza Recent Development

11.3 Thermo Fisher

11.3.1 Thermo Fisher Company Details

11.3.2 Thermo Fisher Business Overview

11.3.3 Thermo Fisher CGT CDMO Introduction

11.3.4 Thermo Fisher Revenue in CGT CDMO Business (2021–2026)

11.3.5 Thermo Fisher Recent Development

11.4 ACG Biologics

11.4.1 ACG Biologics Company Details

11.4.2 ACG Biologics Business Overview

11.4.3 ACG Biologics CGT CDMO Introduction

11.4.4 ACG Biologics Revenue in CGT CDMO Business (2021–2026)

11.4.5 ACG Biologics Recent Development

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec CGT CDMO Introduction

11.5.4 WuXi AppTec Revenue in CGT CDMO Business (2021–2026)

11.5.5 WuXi AppTec Recent Development

11.6 Charles River

11.6.1 Charles River Company Details

11.6.2 Charles River Business Overview

11.6.3 Charles River CGT CDMO Introduction

11.6.4 Charles River Revenue in CGT CDMO Business (2021–2026)

11.6.5 Charles River Recent Development

11.7 Oxford Biomedica (OXB)

11.7.1 Oxford Biomedica (OXB) Company Details

11.7.2 Oxford Biomedica (OXB) Business Overview

11.7.3 Oxford Biomedica (OXB) CGT CDMO Introduction

11.7.4 Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2021–2026)

11.7.5 Oxford Biomedica (OXB) Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis CGT CDMO Introduction

11.8.4 Novartis Revenue in CGT CDMO Business (2021–2026)

11.8.5 Novartis Recent Development

11.9 OBiO

11.9.1 OBiO Company Details

11.9.2 OBiO Business Overview

11.9.3 OBiO CGT CDMO Introduction

11.9.4 OBiO Revenue in CGT CDMO Business (2021–2026)

11.9.5 OBiO Recent Development

11.10 GenScript

11.10.1 GenScript Company Details

11.10.2 GenScript Business Overview

11.10.3 GenScript CGT CDMO Introduction

11.10.4 GenScript Revenue in CGT CDMO Business (2021–2026)

11.10.5 GenScript Recent Development

11.11 Pharmaron

11.11.1 Pharmaron Company Details

11.11.2 Pharmaron Business Overview

11.11.3 Pharmaron CGT CDMO Introduction

11.11.4 Pharmaron Revenue in CGT CDMO Business (2021–2026)

11.11.5 Pharmaron Recent Development

11.12 Porton

11.12.1 Porton Company Details

11.12.2 Porton Business Overview

11.12.3 Porton CGT CDMO Introduction

11.12.4 Porton Revenue in CGT CDMO Business (2021–2026)

11.12.5 Porton Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

WuXi AppTec

OBiO

GenScript

Porton

Lonza

Pharmaron

Catalent

Thermo Fisher

Oxford Biomedica (OXB)

Novartis

ACG Biologics

Charles River

List of Tables

Table 1. Global CGT CDMO Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Immune Cells

Table 3. Key Players of Stem Cells

Table 4. Key Players of Viral Vectors

Table 5. Key Players of Plasmid DNA

Table 6. Global CGT CDMO Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global CGT CDMO Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global CGT CDMO Market Size by Region (US$ Million), 2021–2026

Table 9. Global CGT CDMO Market Share by Region (2021–2026)

Table 10. Global CGT CDMO Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global CGT CDMO Market Share by Region (2027–2032)

Table 12. CGT CDMO Market Trends

Table 13. CGT CDMO Market Drivers

Table 14. CGT CDMO Market Challenges

Table 15. CGT CDMO Market Restraints

Table 16. Global CGT CDMO Revenue by Players (US$ Million), 2021–2026

Table 17. Global CGT CDMO Market Share by Players (2021–2026)

Table 18. Global Top CGT CDMO Players by Tier (Tier 1, Tier 2, and Tier 3), based on CGT CDMO Revenue, 2025

Table 19. Ranking of Global Top CGT CDMO Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by CGT CDMO Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of CGT CDMO, Headquarters and Area Served

Table 22. Global Key Players of CGT CDMO, Products and Applications

Table 23. Global Key Players of CGT CDMO, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global CGT CDMO Market Size by Type (US$ Million), 2021–2026

Table 26. Global CGT CDMO Revenue Market Share by Type (2021–2026)

Table 27. Global CGT CDMO Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global CGT CDMO Revenue Market Share by Type (2027–2032)

Table 29. Global CGT CDMO Market Size by Application (US$ Million), 2021–2026

Table 30. Global CGT CDMO Revenue Market Share by Application (2021–2026)

Table 31. Global CGT CDMO Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global CGT CDMO Revenue Market Share by Application (2027–2032)

Table 33. North America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America CGT CDMO Market Size by Country (US$ Million), 2021–2026

Table 35. North America CGT CDMO Market Size by Country (US$ Million), 2027–2032

Table 36. Europe CGT CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe CGT CDMO Market Size by Country (US$ Million), 2021–2026

Table 38. Europe CGT CDMO Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific CGT CDMO Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific CGT CDMO Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific CGT CDMO Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America CGT CDMO Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America CGT CDMO Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa CGT CDMO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa CGT CDMO Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa CGT CDMO Market Size by Country (US$ Million), 2027–2032

Table 48. Catalent Company Details

Table 49. Catalent Business Overview

Table 50. Catalent CGT CDMO Product

Table 51. Catalent Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 52. Catalent Recent Development

Table 53. Lonza Company Details

Table 54. Lonza Business Overview

Table 55. Lonza CGT CDMO Product

Table 56. Lonza Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 57. Lonza Recent Development

Table 58. Thermo Fisher Company Details

Table 59. Thermo Fisher Business Overview

Table 60. Thermo Fisher CGT CDMO Product

Table 61. Thermo Fisher Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 62. Thermo Fisher Recent Development

Table 63. ACG Biologics Company Details

Table 64. ACG Biologics Business Overview

Table 65. ACG Biologics CGT CDMO Product

Table 66. ACG Biologics Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 67. ACG Biologics Recent Development

Table 68. WuXi AppTec Company Details

Table 69. WuXi AppTec Business Overview

Table 70. WuXi AppTec CGT CDMO Product

Table 71. WuXi AppTec Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 72. WuXi AppTec Recent Development

Table 73. Charles River Company Details

Table 74. Charles River Business Overview

Table 75. Charles River CGT CDMO Product

Table 76. Charles River Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 77. Charles River Recent Development

Table 78. Oxford Biomedica (OXB) Company Details

Table 79. Oxford Biomedica (OXB) Business Overview

Table 80. Oxford Biomedica (OXB) CGT CDMO Product

Table 81. Oxford Biomedica (OXB) Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 82. Oxford Biomedica (OXB) Recent Development

Table 83. Novartis Company Details

Table 84. Novartis Business Overview

Table 85. Novartis CGT CDMO Product

Table 86. Novartis Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 87. Novartis Recent Development

Table 88. OBiO Company Details

Table 89. OBiO Business Overview

Table 90. OBiO CGT CDMO Product

Table 91. OBiO Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 92. OBiO Recent Development

Table 93. GenScript Company Details

Table 94. GenScript Business Overview

Table 95. GenScript CGT CDMO Product

Table 96. GenScript Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 97. GenScript Recent Development

Table 98. Pharmaron Company Details

Table 99. Pharmaron Business Overview

Table 100. Pharmaron CGT CDMO Product

Table 101. Pharmaron Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 102. Pharmaron Recent Development

Table 103. Porton Company Details

Table 104. Porton Business Overview

Table 105. Porton CGT CDMO Product

Table 106. Porton Revenue in CGT CDMO Business (US$ Million), 2021–2026

Table 107. Porton Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. CGT CDMO Picture

Figure 2. Global CGT CDMO Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global CGT CDMO Market Share by Type: 2025 vs 2032

Figure 4. Immune Cells Features

Figure 5. Stem Cells Features

Figure 6. Viral Vectors Features

Figure 7. Plasmid DNA Features

Figure 8. Global CGT CDMO Market Size by Application (US$ Million), 2021–2032

Figure 9. Global CGT CDMO Market Share by Application: 2025 vs 2032

Figure 10. Pharmaceutical and Biotechnology Companies Case Studies

Figure 11. Research and Academic Institutions Case Studies

Figure 12. Hospital Case Studies

Figure 13. Others Case Studies

Figure 14. CGT CDMO Report Years Considered

Figure 15. Global CGT CDMO Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global CGT CDMO Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global CGT CDMO Market Share by Region: 2025 vs 2032

Figure 18. Global CGT CDMO Market Share by Players in 2025

Figure 19. Global CGT CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by CGT CDMO Revenue in 2025

Figure 21. North America CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America CGT CDMO Market Share by Country (2021–2032)

Figure 23. United States CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe CGT CDMO Market Share by Country (2021–2032)

Figure 27. Germany CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific CGT CDMO Market Share by Region (2021–2032)

Figure 35. China CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America CGT CDMO Market Share by Country (2021–2032)

Figure 43. Mexico CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa CGT CDMO Market Share by Country (2021–2032)

Figure 47. Israel CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE CGT CDMO Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Catalent Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 51. Lonza Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 52. Thermo Fisher Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 53. ACG Biologics Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 54. WuXi AppTec Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 55. Charles River Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 56. Oxford Biomedica (OXB) Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 57. Novartis Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 58. OBiO Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 59. GenScript Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 60. Pharmaron Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 61. Porton Revenue Growth Rate in CGT CDMO Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Therapy CDMO Services Market Research Report 2025

Global Chemical CDMO Market Research Report 2024

Global Full Service CDMO Market Research Report 2024

Global Plasmid DNA CDMO Service Market Research Report 2024

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Cell and Gene Therapy CDMO Market Research Report 2024

Global Viral Vector Manufacturing CDMO Services Market Research Report 2024

Global Gene Cell Therapy CDMO Market Research Report 2024

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Global Contract Dose Manufacturing Market Insights Forecast to 2030

Global mRNA CDMO Service Market Research Report 2024

Global Bio Contract Development and Manufacturing Organizations CDMOs Market Insights Forecast to 2030

Global Pharmaceutical CDMO Market Research Report 2025

Global Cell Therapy CDMO Market Research Report 2025

Global Biopharmaceutical CDMO Market Research Report 2025

Global Biopharmaceutical CDMO Service Market Research Report 2024

Global Oligonucleotide CDMO Market Research Report 2025

Global Formulation CDMO Services Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions